YBX1 (Y-Box Binding Protein 1) is a multifunctional DNA- and RNA-binding protein that plays critical roles in transcriptional regulation, mRNA splicing, translation, and stress response. As a member of the Y-box binding protein family, YBX1 contains a conserved cold-shock domain (CSD) that enables nucleic acid binding. In the central nervous system (CNS), YBX1 is essential for neuronal development, stress granule dynamics, protein quality control, and maintenance of RNA homeostasis. Dysregulation of YBX1 function has been implicated in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's disease (AD).
|
|
| Gene Symbol |
YBX1 |
| Full Name |
Y-Box Binding Protein 1 |
| Chromosomal Location |
1p34.2 |
| NCBI Gene ID |
5102 |
| OMIM |
113703 |
| Ensembl ID |
ENSG00000165996 |
| UniProt ID |
P62962 |
YBX1 encodes Y-box binding protein 1, a multifunctional nucleic acid-binding protein involved in transcriptional regulation, mRNA splicing, and translation. YBX1 contains a conserved cold-shock domain (CSD) and functions as a transcriptional activator or repressor depending on context. In the nervous system, YBX1 is involved in neuronal development, stress response, and protein quality control.
YBX1 functions as a transcriptional regulator by binding to Y-box elements (CTGATTGCA) in gene promoters:
- Activates transcription of genes involved in cell survival and proliferation
- Represses genes involved in apoptosis
- Modulates expression of stress response genes
- Regulates estrogen receptor (ER) target genes
YBX1 participates in multiple aspects of mRNA metabolism:
- Pre-mRNA splicing: Interacts with spliceosome components
- mRNA stability: Binds to AU-rich elements (AREs) to regulate mRNA half-life
- Translation: Regulates both cap-dependent and internal ribosome entry site (IRES)-mediated translation
¶ Stress Response and Stress Granules
During cellular stress, YBX1 localizes to stress granules (SGs):
- SGs are membrane-less organelles formed by liquid-liquid phase separation
- YBX1 binding to mRNAs helps regulate translation arrest during stress
- Impaired SG dynamics contribute to neurodegeneration
- YBX1 interacts with proteins mutated in ALS (TDP-43, FUS, TIA1)
YBX1 participates in DNA repair:
- Binds to damaged DNA sites
- Interacts with p53 and modulates p53-dependent transcription
- Involved in nucleotide excision repair (NER)
YBX1 contains several functional domains:
- Cold-shock domain (CSD): ~70 amino acids, binds nucleic acids
- C-terminal domain (CTD): Rich in aromatic and acidic residues, mediates protein interactions
- Multiple phosphorylation sites: Regulates subcellular localization and function
The protein can form homodimers and heterodimers with other Y-box binding proteins (YBX2, YBX3).
YBX1 is broadly expressed in the CNS:
YBX1 is genetically and functionally linked to ALS:
- Rare pathogenic variants in YBX1 cause familial ALS
- YBX1-positive stress granules accumulate in ALS motor neurons
- Impaired RNA metabolism due to YBX1 dysfunction contributes to motor neuron degeneration
- YBX1 interacts with other ALS-associated proteins (TDP-43, FUS, SOD1)
In Parkinson's disease:
- YBX1 regulates alpha-synuclein (SNCA) mRNA translation and stability
- YBX1 dysfunction may contribute to alpha-synuclein aggregation
- Altered YBX1 expression in substantia nigra of PD patients
- Impaired stress response in dopaminergic neurons
In Alzheimer's disease:
- YBX1 regulates APP (Amyloid Precursor Protein) mRNA processing
- Alternative splicing of tau (MAPT) mRNA is modulated by YBX1
- YBX1 levels correlate with cognitive decline in AD patients
- Stress granule pathology in AD brains involves YBX1
Dysregulated YBX1 expression is common in cancers:
- Overexpression correlates with poor prognosis
- Promotes tumor cell proliferation and metastasis
- YBX1 is a potential therapeutic target
YBX1 function can be modulated through:
- Antisense oligonucleotides (ASOs) targeting YBX1
- Small molecules that modulate stress granule dynamics
- RNA splicing modifiers
Approaches to improve stress granule function:
- Compounds that promote proper phase separation
- Autophagy enhancers to clear dysfunctional granules
Potential for:
- Wild-type YBX1 delivery to neurons
- CRISPR-based correction of pathogenic variants
Current research focuses on:
- Understanding YBX1 mutations that cause ALS
- Developing stress granule modulators
- Identifying downstream target mRNAs
- Exploring YBX1 as a biomarker
The study of Ybx1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:28453756 - YBX1 in ALS pathogenesis
- PMID:29628861 - YBX1 and stress granule dynamics
- PMID:31422874 - YBX1 in neurodegeneration
- PMID:32977328 - YBX1 mutations in ALS/FTD
- PMID:34285204 - YBX1 in Alzheimer's disease
- PMID:35697642 - Stress granules in neurodegeneration
- PMID:36598210 - YBX1 and alpha-synuclein
- PMID:37501522 - RNA binding proteins in ALS